CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)
CASI Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of innovative treatments for cancer, infectious diseases, and other serious conditions. Founded in 2009 and headquartered in Rockville, Maryland, CASI aims to leverage its expertise in drug repurposing and development through strategic collaborations and regulatory approvals, primarily in China and other international markets. The company focuses on bringing both innovative and re-purposed therapies to underserved patient populations worldwide.
Company News
CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.
HC Wainwright & Co. has decided to maintain its Buy rating of CASI Pharmaceuticals (NASDAQ:CASI) and raise its price target from $10.00 to $12.00. Shares of CASI Pharmaceuticals are trading up 1.33% over the last 24 hours, at $4.56 per share. A move to $12.00 would account for a 163.16% increase from the current share price. About CASI Pharmaceut...
Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.